Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.4.6 (
urease
)
7,490
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The susceptibility of Helicobacter pylori to the antimicrobial system involving
lactoperoxidase
, hydrogen peroxide and thiocyanate was investigated. The inhibitory effect of the system on the
urease
activity of H. pylori, which plays a role in its colonisation of the stomach, was also investigated. Twelve H. pylori strains examined, including 10 clinical isolates, were all inhibited by the peroxidase system in brain-heart infusion broth supplemented with fetal calf serum, but to different extents. The killing effect was observed within 3 h. Although bacterial viability recovered afterwards, there was still a clear difference between cultures incubated in the presence of the complete system and control cultures incubated in the absence of
lactoperoxidase
, after incubation for 24 h. The
urease
activity and viability of H. pylori were both inactivated by this system in phosphate buffer. These effects were dependent on the concentrations of both
lactoperoxidase
and hydrogen peroxide and were abolished by the addition of cysteine. Furthermore, these effects were observed when bovine
lactoperoxidase
was replaced by recombinant human
lactoperoxidase
or native or recombinant human myeloperoxidase. The peroxidase system found in saliva and milk may contribute to the host defence against H. pylori infection and inhibition of transmission via the oral route.
...
PMID:Susceptibility of Helicobacter pylori and its urease activity to the peroxidase-hydrogen peroxide-thiocyanate antimicrobial system. 1187 18